CISPLATIN for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 988 adverse event reports in the FDA FAERS database where CISPLATIN was used for Lung neoplasm malignant.
Most Reported Side Effects for CISPLATIN
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 4,359 | 9.2% | 746 | 1,415 |
| Disease progression | 3,746 | 7.9% | 880 | 500 |
| Neutropenia | 3,095 | 6.5% | 464 | 920 |
| Febrile neutropenia | 3,010 | 6.3% | 580 | 1,580 |
| Nausea | 2,923 | 6.2% | 282 | 1,470 |
| Drug ineffective | 2,608 | 5.5% | 744 | 607 |
| Thrombocytopenia | 2,565 | 5.4% | 410 | 911 |
| Anaemia | 2,530 | 5.3% | 338 | 1,111 |
| Vomiting | 2,326 | 4.9% | 286 | 1,314 |
| Diarrhoea | 2,022 | 4.3% | 376 | 1,069 |
| Malignant neoplasm progression | 2,004 | 4.2% | 726 | 446 |
| Pyrexia | 1,863 | 3.9% | 243 | 1,263 |
| Myelosuppression | 1,849 | 3.9% | 106 | 843 |
| Acute kidney injury | 1,783 | 3.8% | 279 | 1,162 |
| Fatigue | 1,394 | 2.9% | 161 | 561 |
Other Indications for CISPLATIN
Diffuse large b-cell lymphoma (2,703)
Product used for unknown indication (2,614)
Non-small cell lung cancer (1,762)
Plasma cell myeloma (1,239)
Oesophageal carcinoma (1,094)
Lung adenocarcinoma (1,003)
Osteosarcoma (975)
Chemotherapy (958)
Cholangiocarcinoma (923)
Gastric cancer (802)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)